Bumetanide
Showing 1 - 25 of 42
Alzheimer Trial in Stanford (Bumetanide, Placebo)
Not yet recruiting
- Alzheimer Disease
- Bumetanide
- Placebo
-
Stanford, CaliforniaStanford University
Sep 18, 2023
Heart Failure; With Decompensation Trial in Rochester (Bumetanide, Furosemide)
Not yet recruiting
- Heart Failure; With Decompensation
- Bumetanide
- Furosemide
-
Rochester, MinnesotaMayo Clinic in Rochester
Sep 7, 2023
Heart Failure Trial in New Haven (Bumetanide Injection)
Recruiting
- Heart Failure
- Bumetanide Injection
-
New Haven, ConnecticutYale University
Sep 22, 2022
HF - Heart Failure, Diabetes Trial in Chicago (Bumetanide 0.5 mg, dapaglifozin 5 mg, eplerenone 25 mg)
Withdrawn
- HF - Heart Failure
- Diabetes Mellitus
- Bumetanide 0.5 mg, dapaglifozin 5 mg, eplerenone 25 mg
-
Chicago, IllinoisNorthwestern University
May 4, 2022
Autistic Disorder Trial (Bumetanide, Placebo)
Withdrawn
- Autistic Disorder
- Bumetanide
- Placebo
- (no location specified)
Jun 1, 2021
Acute Heart Failure, Diuretics Drug Reactions Trial in Jette, Hasselt (diagnostic test, drug, other)
Recruiting
- Acute Heart Failure
- Diuretics Drug Reactions
- UNa measurement after intravenous loop diuretic bolus
- +9 more
-
Jette, Brussels, Belgium
- +1 more
Jun 12, 2022
Heart Failure Trial in New Haven (Increased Intravenous Bolus Loop Diuretic Dose (Bumetanide or Furosemide), IV Chlorothiazide)
Active, not recruiting
- Heart Failure
- Increased Intravenous Bolus Loop Diuretic Dose (Bumetanide or Furosemide)
- IV Chlorothiazide
-
New Haven, ConnecticutYale University
Jul 21, 2022
Unresectable Hepatocellular Carcinoma Trial in United States (Hepatic artery embolization (HAE), Bumetanide)
Active, not recruiting
- Unresectable Hepatocellular Carcinoma
- Hepatic artery embolization (HAE)
- Bumetanide
-
Basking Ridge, New Jersey
- +4 more
Nov 22, 2021
Chronic Kidney Disease, Hypertension Trial in Houston (Diuretic augmentation (hydrochlorothiazide, chlorthalidone, furosemide,
Not yet recruiting
- Chronic Kidney Disease
- Hypertension
- Diuretic augmentation (hydrochlorothiazide, chlorthalidone, furosemide, torsemide, or bumetanide)
-
Houston, TexasMichael E. DeBakey VA Medical Center, Houston, TX
Aug 3, 2022
Autism Trial in Tanta (Bumetanide, Placebo)
Recruiting
- Autism
- Bumetanide
- Placebo
-
Tanta, EgyptSherief Abd-Elsalam
Feb 19, 2021
Autism Spectrum Disorder Trial in Shanghai (Bumetanide, Placebo)
Completed
- Autism Spectrum Disorder
- Bumetanide
- Placebo
-
Shanghai, Shanghai, ChinaXinhua Hospital
Feb 25, 2021
Epilepsy, Alzheimer, Epilepsy Intractable Trial in Lincoln (NPT 2042 (bumetanide analog) or Matching Placebo)
Not yet recruiting
- Epilepsy
- +2 more
- NPT 2042 (bumetanide analog) or Matching Placebo
-
Lincoln, NebraskaCelerion
Aug 12, 2022
Autism Spectrum Disorder (ASD) Trial in Worldwide (BUMETANIDE/S95008, PLACEBO)
Terminated
- Autism Spectrum Disorder (ASD)
- BUMETANIDE/S95008
- PLACEBO
-
Staten Island, New York
- +49 more
Dec 20, 2021
Seizures Trial in Boston (Bumetanide, Normal Saline as Placebo)
Completed
- Seizures
- Bumetanide
- Normal Saline as Placebo
-
Boston, Massachusetts
- +3 more
Dec 15, 2020
Autism Spectrum Disorder (ASD) Trial in Worldwide (Bumetanide Oral Solution, Placebo)
Terminated
- Autism Spectrum Disorder (ASD)
- Bumetanide Oral Solution
- Placebo
-
Curitiba, Brazil
- +44 more
Mar 11, 2022
Renal Insufficiency, Chronic Trial in Mexico City (Chlorthalidone, Bumetanide)
Completed
- Renal Insufficiency, Chronic
- Chlorthalidone
- Bumetanide
-
Mexico City, MexicoHospital General de Mexico
Nov 4, 2020
Heart Failure Trial (Placebo, Amiloride, Bendroflumethiazide)
Not yet recruiting
- Heart Failure
- Placebo
- +2 more
- (no location specified)
Feb 21, 2023
Parkinson Disease Trial in Nantes (Bumetanide white, oblong, scored tablet, Placebo white, oblong, scored tablet)
Unknown status
- Parkinson Disease
- Bumetanide white, oblong, scored tablet
- Placebo white, oblong, scored tablet
-
Nantes, FranceChu Nantes
Jul 22, 2019
Acute Heart Failure Trial (Dexamethasone, Prednisone)
Not yet recruiting
- Acute Heart Failure
- (no location specified)
Mar 30, 2023
Congenital Heart Disease, Heart Failure, Heart Failure With Reduced Ejection Fraction Trial in Mexico City (Sacubitril 49 MG /
Not yet recruiting
- Congenital Heart Disease
- +2 more
- Sacubitril 49 MG / Valsartan 51 MG [Entresto] BID
- Empagliflozin 10 MG OD
-
Mexico City, MexicoNational Institute of Cardiology Ignacio Chavez
Oct 31, 2022
Chronic Kidney Insufficiency Trial in Albuquerque (Bumetanide, Cool Dialysate)
Unknown status
- Chronic Kidney Insufficiency
- Bumetanide
- Cool Dialysate
-
Albuquerque, New MexicoDialysis Clinic Inc. - Indian School
Apr 16, 2019
Chronic Kidney Disease Trial in Dallas (Diuretic initiation or augmentation)
Withdrawn
- Chronic Kidney Disease
- Diuretic initiation or augmentation
-
Dallas, TexasVA North Texas Health Care System Dallas VA Medical Center, Dall
Dec 1, 2021